In this Med-IQ Express activity hosted on Medscape, faculty describe the rationale for using molecular markers in the diagnosis and prognosis of colon cancer.
Continuing Medical Education
In this short case-based activity, meet Sam, a 41-year-old man who presents to the emergency department with abdominal pain and bloating and is later found to have an inflammatory pancreatic fluid collection. As you move through this activity, read through links to useful resources to help you make clinical management decisions for Sam. In addition, find out how gastroenterologist Rebecca Burbridge, MD, would classify and manage this patient’s inflammatory pancreatic fluid collection.
Rebecca Burbridge, MD
Associate Professor of Medicine, Division of Gastroenterology
Director of Advanced Endoscopy
Associate Director of Clinical Endoscopy
This 15-minute activity features a brief video introduction by faculty expert Dr. Muir in which he discusses how the new combination therapies glecaprevir/pibrentasvir and sofosbuvir/velpatasvir/voxilaprevir have changed the treatment landscape. The activity then continues with a text-based review of the recent advances in direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) and the clinical trials that led to the approval of these new agents.
Andrew Muir, MD
Professor of Medicine; Chief, Division of Gastroenterology in the Department of Medicine; Director, GI/Hepatology Program